| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.33B | 10.01B | 10.41B | -6.26B | 65.96B |
| Gross Profit | 21.01B | 10.01B | 10.41B | -30.68B | 23.28B |
| EBITDA | 35.51B | 0.00 | 0.00 | -35.90B | 3.71B |
| Net Income | 10.86B | 9.62B | 1.77B | -27.06B | 1.60B |
Balance Sheet | |||||
| Total Assets | 1.06T | 984.33B | 968.10B | 955.33B | 1.57T |
| Cash, Cash Equivalents and Short-Term Investments | 70.88B | 74.00K | 85.00K | 122.00K | 497.75M |
| Total Debt | 966.07B | 327.76B | 854.51B | 831.85B | 419.77B |
| Total Liabilities | 1.00T | 934.56B | 920.07B | 906.95B | 1.46T |
| Stockholders Equity | 62.26B | 56.50B | 49.75B | 51.11B | 81.72B |
Cash Flow | |||||
| Free Cash Flow | -30.97B | 95.72B | 18.85B | -34.12B | 94.44B |
| Operating Cash Flow | -30.92B | 99.13B | 19.25B | -33.58B | 95.42B |
| Investing Cash Flow | 19.15B | -49.05B | -11.70B | 8.58B | 43.41B |
| Financing Cash Flow | -5.46B | -32.82B | -30.92B | -57.85B | -92.35B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | HK$3.78B | 6.62 | 6.66% | 0.44% | 28.57% | 342.11% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
64 Neutral | HK$1.88B | 16.32 | 20.74% | ― | 56.35% | ― | |
55 Neutral | HK$1.63B | 2.48 | 1.24% | ― | -31.46% | -10.06% | |
53 Neutral | HK$61.79B | 4.42 | 17.77% | ― | -16.24% | -14.24% | |
52 Neutral | HK$43.89B | 6.62 | 1.61% | 1.92% | -15.83% | -32.08% | |
44 Neutral | HK$10.53B | -7.89 | -6.64% | 1.07% | -23.19% | 93.53% |